Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex
- PMID: 26434588
- DOI: 10.1038/onc.2015.358
Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex
Abstract
Functions of extracellular vesicles including exosomes in the pathogenesis of tuberous sclerosis complex (TSC) have not yet been studied. We report that the extracellular vesicles such as exosomes derived from tuberous sclerosis 1 (Tsc1)-null cells transform phenotypes of neighboring wild-type cells in vivo in such manner that they become functionally similar to Tsc1-null cells. The loss of Tsc1 in the mouse neural tube increases the number of the wild-type neuronal progenitors, which is followed by the precocious and transient acceleration of neuronal differentiation of these cells. The mechanisms regulating these changes involve the exosomal delivery of exosomal shuttle Notch1 and Rheb esRNA and component of γ-secretase complex presenilin 1 from Tsc1-null cells to wild-type cells leading to the activation of Notch and Rheb signaling in the recipient cells. The exosome-mediated mechanisms may also operate in the cells of angiomyolipoma (AML), which develops as a result of mutations in TSC1/TSC2 genes in TSC patients, because we observed the reactivation of mammalian target of rapamycin and Notch pathways, driven by the delivery of Rheb and Notch1 esRNA, in AML cells depleted of Rheb that were treated with the exosomes purified from AML cells with the constitutively high Rheb levels.
Similar articles
-
The evolutionarily conserved TSC/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development.J Clin Invest. 2010 Jan;120(1):93-102. doi: 10.1172/JCI40221. Epub 2009 Dec 28. J Clin Invest. 2010. PMID: 20038815 Free PMC article.
-
PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex.Sci Rep. 2015 Sep 28;5:14534. doi: 10.1038/srep14534. Sci Rep. 2015. PMID: 26412398 Free PMC article.
-
Notch transactivates Rheb to maintain the multipotency of TSC-null cells.Nat Commun. 2017 Nov 29;8(1):1848. doi: 10.1038/s41467-017-01845-1. Nat Commun. 2017. PMID: 29184052 Free PMC article.
-
Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.Oncogene. 2005 Nov 14;24(50):7475-81. doi: 10.1038/sj.onc.1209090. Oncogene. 2005. PMID: 16288294 Review.
-
Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R251-8. doi: 10.1093/hmg/ddi260. Hum Mol Genet. 2005. PMID: 16244323 Review.
Cited by
-
Neurophysiology and Regulation of the Balance Between Excitation and Inhibition in Neocortical Circuits.Biol Psychiatry. 2017 May 15;81(10):821-831. doi: 10.1016/j.biopsych.2016.09.017. Epub 2016 Sep 29. Biol Psychiatry. 2017. PMID: 27865453 Free PMC article. Review.
-
Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy.J Clin Invest. 2019 Oct 1;129(10):4207-4223. doi: 10.1172/JCI127032. J Clin Invest. 2019. PMID: 31483294 Free PMC article.
-
Biallelic Mutations in TSC2 Lead to Abnormalities Associated with Cortical Tubers in Human iPSC-Derived Neurons.J Neurosci. 2019 Nov 20;39(47):9294-9305. doi: 10.1523/JNEUROSCI.0642-19.2019. Epub 2019 Oct 7. J Neurosci. 2019. PMID: 31591157 Free PMC article.
-
Tuberous sclerosis complex exhibits a new renal cystogenic mechanism.Physiol Rep. 2019 Jan;7(2):e13983. doi: 10.14814/phy2.13983. Physiol Rep. 2019. PMID: 30675765 Free PMC article.
-
Tuberous Sclerosis Complex cell-derived EVs have an altered protein cargo capable of regulating their microenvironment and have potential as disease biomarkers.J Extracell Vesicles. 2023 Jun;12(6):e12336. doi: 10.1002/jev2.12336. J Extracell Vesicles. 2023. PMID: 37337371 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical